882 related articles for article (PubMed ID: 2147933)
1. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion.
Tomita Y; Nishimura Y; Harada N; Eto M; Ayukawa K; Yoshikai Y; Nomoto K
J Immunol; 1990 Dec; 145(12):4026-36. PubMed ID: 2147933
[TBL] [Abstract][Full Text] [Related]
2. Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion.
Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Nomoto K
J Immunol; 1990 Sep; 145(5):1303-10. PubMed ID: 2143514
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of cyclophosphamide-induced tolerance to IE-encoded alloantigens--evidence of clonal deletion in MHC antigen-reactive cells for skin allograft rejection.
Tomita Y; Ayukawa K; Yoshikai Y; Nomoto K
Transplantation; 1992 Mar; 53(3):602-12. PubMed ID: 1347961
[TBL] [Abstract][Full Text] [Related]
4. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen.
Tomita Y; Khan A; Sykes M
J Immunol; 1994 Aug; 153(3):1087-98. PubMed ID: 8027542
[TBL] [Abstract][Full Text] [Related]
5. Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice.
Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Maeda T; Ando T; Nomoto K
J Immunol; 1991 Mar; 146(5):1402-9. PubMed ID: 1671578
[TBL] [Abstract][Full Text] [Related]
6. The requirement of intrathymic mixed chimerism and clonal deletion for a long-lasting skin allograft tolerance in cyclophosphamide-induced tolerance.
Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Nomoto K
Eur J Immunol; 1990 Sep; 20(9):2005-13. PubMed ID: 2209702
[TBL] [Abstract][Full Text] [Related]
7. Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance?
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Jan; 144(2):463-73. PubMed ID: 2136891
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system.
Nishimura Y; Mayumi H; Tomita Y; Eto M; Maeda T; Nomoto K
J Immunol; 1991 Apr; 146(8):2639-47. PubMed ID: 1707914
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of neonatal transplantation tolerance.
Streilein JW; Mohler K; Wood PJ
Transplant Proc; 1987 Dec; 19(6 Suppl 7):82-7. PubMed ID: 2962357
[TBL] [Abstract][Full Text] [Related]
10. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
[TBL] [Abstract][Full Text] [Related]
11. Characterization of cytotoxic cells in mice rendered neonatally tolerant of MHC alloantigens: evidence for repertoire modification.
Wood PJ; Strome PG; Streilein JW
J Immunol; 1987 Jun; 138(11):3661-8. PubMed ID: 2884256
[TBL] [Abstract][Full Text] [Related]
12. Similarity and difference in the mechanisms of neonatally induced tolerance and cyclophosphamide-induced tolerance in mice.
Eto M; Mayumi H; Nishimura Y; Maeda T; Yoshikai Y; Nomoto K
J Immunol; 1991 Oct; 147(8):2439-46. PubMed ID: 1918974
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow-derived cells are essential for intrathymic deletion of self-reactive T cells in both the host- and donor-derived thymocytes of fully allogeneic bone marrow chimeras.
Yoshikai Y; Ogimoto M; Matsuzaki G; Nomoto K
J Immunol; 1990 Jul; 145(2):505-9. PubMed ID: 2114441
[TBL] [Abstract][Full Text] [Related]
14. Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens.
Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nomoto K
J Exp Med; 1990 Jan; 171(1):97-113. PubMed ID: 2136907
[TBL] [Abstract][Full Text] [Related]
15. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
[TBL] [Abstract][Full Text] [Related]
16. Cellular mechanisms that maintain neonatally-induced tolerance of class II alloantigens. Evidence that precursor cytotoxic T cells are present but silenced.
Matriano JA; Socarras S; Streilein JW
J Immunol; 1994 Aug; 153(4):1515-26. PubMed ID: 8046230
[TBL] [Abstract][Full Text] [Related]
17. Characterization of donor chimerism, alloreactive host T cells and memory cell development in thymi from mice resistant to neonatal transplantation tolerance.
Ruiz P; Nassiri M; Viciana AL; Padmanabhan J; Streilein JW
J Immunol; 1995 Jan; 154(2):633-43. PubMed ID: 7814872
[TBL] [Abstract][Full Text] [Related]
18. Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras.
Taniguchi H; Abe M; Shirai T; Fukao K; Nakauchi H
J Immunol; 1995 Dec; 155(12):5631-6. PubMed ID: 7499847
[TBL] [Abstract][Full Text] [Related]
19. Interference with cyclophosphamide-induced skin allograft tolerance by cyclosporin A.
Nomoto K; Eto M; Yanaga K; Nishimura Y; Maeda T; Nomoto K
J Immunol; 1992 Oct; 149(8):2668-74. PubMed ID: 1401906
[TBL] [Abstract][Full Text] [Related]
20. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]